Tumor-Targeting Probiotic Bacteria: A Breakthrough in Targeted Cancer Therapy

About this episode

This episode discusses an innovative approach to cancer treatment using engineered probiotic bacteria to target tumors.

In this episode, we explore an innovative approach to cancer treatment using engineered probiotic bacteria, an emerging strategy that could transform how tumors are targeted and treated. You’ll learn: What tumor-targeting probiotic bacteria are and how they work How engineered microbes can locate tumors and produce cancer-fighting drugs on site Why E. coli Nissle 1917 is being used as a safe and promising probiotic strain How the drug romidepsin is delivered directly within the...

People in this episode

Host: DR. CHRISTINA NG VAN TZE

Topics covered

• cancer treatment
• probiotic bacteria
• targeted therapy
• engineered microbes
• tumor targeting

Keywords

• cancer therapy
• probiotics
• tumor targeting
• E. coli
• romidepsin
• engineered microbes

Mentioned in this episode

Products: E. coli Nissle 1917, romidepsin

More episodes of The Onco Life Podcast

• Personalized Cancer Vaccine Shows Long-Term Promise for High-Risk Melanoma Patients · June 1, 2026 · 2 min
• New Targeted Drug sac-TMT Improves Survival in Advanced Endometrial Cancer · May 29, 2026 · 2 min
• Where to Get Uterine Cancer Treatment in Malaysia: What Patients Should Know · May 20, 2026 · 19 min
• What Happens if Cervical Cancer Treatment Fails or the Cancer Returns? · May 19, 2026 · 19 min
• Biotin Supplements May Interfere With Cancer Test Results: What Patients Need to Know · May 19, 2026 · 2 min
• Blood Test Could Help Predict Breast Cancer Immunotherapy Success With Liquid Biopsy Research · May 19, 2026 · 2 min